Xontogeny

Creating value through
purposeful program strategy

Xontogeny’s team brings decades of deep operational, strategic and investment experience across treatment modalities and therapeutic areas with a proven track record of success. We prioritize our energy and resources to focus on the careful design of each component of a company’s product development and regulatory plan, from preclinical lead identification through clinical proof of concept data. We believe these choices are essential to the success of any program.

Operational Support

Operational Support

Success takes more than great science. While it is important to start with a strong and promising foundation of basic research, we believe the skills of drug and medical technology development are separate and distinct and the more critical factors that determine success in the clinic.

A sound and thoughtful strategy, driven by an experienced team with focused execution will elevate a great scientific idea to its full potential as a life-changing treatment. We guide entrepreneurs through this process because we understand the challenges of bringing a product to market.  Xontogeny’s experienced team and network brings a track record of success and will be the architects, working side-by-side with you to turn your drug, device or diagnostic into a valuable product.

 

 

 

Finance

Investment

Xontogeny can provide the foundational capital to maximize value of your startup prior to larger rounds of capital, while providing access to our management team and network to avoid cash outlays for experienced talent. Importantly, we work with you to determine the most efficient and impactful deployment of capital to maximize value and minimize early dilution to founders.

We have partnered with one of the top-performing life sciences investment funds, Perceptive Advisors, to create access to capital that can support your product from idea to commercialization. Xontogeny can support your idea from company creation and seed investments, while constructing a capital-efficient plan for Series A and B financings. Furthermore, Xontogeny principals are Partners in the Perceptive Xontogeny Venture Fund (PXV Fund) which can support Series A and B investments to help support the company financially through clinical proof of concept and key value inflections. Our goal is to enable capital-efficient development that creates win-win scenarios for founders and entrepreneurs in avoiding unnecessary dilution in early financing rounds.

Network Access

While we acknowledge that the best and largest talent pools for drug and technology development in the life science industry is concentrated in a limited number of selected geographic hubs, we believe that great ideas and compelling research can come from anywhere. To this end, we give equal consideration to supporting ventures regardless of the source of the technology or where the scientific founder / entrepreneur resides.

Xontogeny operates under the philosophy that there is a limited number of highly experienced, top-tier life science individuals who can mentor and lead the successful design and execution of development programs. By sharing our expertise and driving program strategy across our portfolio, it enables a lean, virtual model of drug and medical technology development by outsourcing the execution of most activities to our global network of proven contract organizations and service providers.

Mentorship

mentorship

The Xontogeny team believes it is our obligation to share the decades of experience we have in driving companies to success with the next generation of biotechnology and life science leaders. We prefer to work closely with entrepreneurs and founders who are knowledgeable and passionate about their idea and technology, rather than build a higher profile team that is often unnecessary in the early development stages.

Our philosophy is rooted in the belief that the scientific founders and entrepreneurs are a critical component of any venture and that synergies are achieved when working with the industry experts that the Xontogeny team and network bring to each collaboration. The entrepreneur is at the heart of the company, providing passion and unwavering dedication that we want to foster and grow.

 

Privacy Preference Center

Advertising

The NID, DSID, IDE cookies are set by DoubleClick (which is owned by Google) to help build a profile of your interests and show you relevant ads on other sites. The other cookies (from google.com) carry out information about how the end user uses the website and any advertising that the end user may have seen before visiting the said website.

NID, IDE, 1P_JAR, AID, ANID, APISID, DSID, DV, HSID, SAPISID, SID, SIDCC, SSID

Analytics

Xontogeny uses these cookies to collect information about how visitors use our Site. We use the information to compile reports and to help us improve the Site. The cookies collect information in an anonymous form, including the number of visitors to the Site, where visitors have come to the Site from and the pages they visited. If you do not allow these cookies we will not be able to include your visit in our statistics. You can read the full Google Analytics privacy policy at: http://www.google.com/policies/privacy/.

_ga,_gat,_gid, _gali

Functionality

The OGPC cookie enables the functionality of Google Maps. s_cc Adobe Site Catalyst cookie, determines whether cookies are enabled in the browser. The s_sq and s_vi, Adobe Site Catalyst cookie, stores information about the previous link clicked within the site as well as identify unique visitors, with an ID and timestamp.

OGPC, s_cc, s_sq, s_vi